X-FAB: Key Segments Are Pushing The Story Forward

X-FAB Silicon Foundries (OTCPK:XFABF) reported robust Q2 2025 results, with revenue up 5% year-over-year to $215.3 million, driven by strong growth in industrial (+37%) and medical (+14%) segments, alongside a 32% sequential increase in SiC revenue. The company raised its full-year revenue guidance to $840-$870 million, supported by a 19% sequential surge in bookings and a $412.9 million backlog. With capacity constraints now resolved and capital expenditures normalizing, X-FAB is poised for improved free cash flow and margin expansion. Despite an 86% stock rally since March, the company trades at approximately 1.6x EV/Sales, representing a significant discount to the sector median, suggesting continued undervaluation relative to its operational execution and strategic growth drivers.

Analysis

X-FAB Silicon Foundries SE (XFABF) has demonstrated strong operational execution and fundamental improvement, as evidenced by its Q2 2025 results. The company reported a 5% year-over-year revenue increase to $215.3 million, with core verticals growing 8%, led by a 37% surge in the industrial segment and 14% in medical. Management's confidence is underscored by an upward revision of full-year revenue guidance to $840-$870 million, supported by a 19% sequential increase in bookings to $207.2 million and a backlog of $412.9 million. Critically, the investment thesis is shifting from a capacity-constrained story to one of execution and margin expansion. The 32% sequential growth in silicon carbide (SiC) revenue signals the successful conversion of prior bookings and represents a key catalyst for future growth and margin leverage. Furthermore, capital expenditures are normalizing, with the peak investment phase largely concluded, paving the way for improved free cash flow generation. Despite these positive developments and a strong balance sheet holding over $158 million in net cash, the company trades at an EV/Sales multiple of approximately 1.6x, a more than 50% discount to the sector median, suggesting the market has not fully priced in its structural improvements and growth trajectory.

Key Decisions for Investors

• Consider the current valuation at ~1.6x EV/Sales as a potential opportunity, given the significant discount to the sector median of over 3x, which appears misaligned with the company's robust execution and raised revenue guidance.
• Closely monitor the ramp-up of the silicon carbide (SiC) business, as its 32% sequential growth is a primary driver for future margin expansion and a potential catalyst for a stock re-rating.
• While the outlook is positive, investors should remain aware of risks, including potential delays in SiC customer qualifications and margin sensitivity to product mix, especially after the stock's recent 86% rally.
• Focus on free cash flow generation in upcoming reports, as the normalization of capital expenditures marks a strategic shift that should structurally improve the company's financial profile and valuation.